Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-17 Sale |
2020-08-19 12:53 pm |
GILEAD SCIENCES INC | GILD | Parsey Merdad Chief Medical Officer |
182 | $68.32 | $12,434 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-26 Option Award |
2021-01-28 7:57 pm |
N/A N/A |
GILEAD SCIENCES INC | GILD | Parsey Merdad Chief Medical Officer |
9,214 | $0 | 11,899 (Direct) |
View |
| 2020-11-10 Exercise |
2020-11-12 5:44 pm |
N/A N/A |
GILEAD SCIENCES INC | GILD | Parsey Merdad Chief Medical Officer |
5,101 | $0 | 26,704 (Direct) |
View |
| 2020-11-10 Tax Withholding |
2020-11-12 5:44 pm |
N/A N/A |
GILEAD SCIENCES INC | GILD | Parsey Merdad Chief Medical Officer |
2,416 | $60.62 | 26,704 (Direct) |
View |
| 2020-08-15 Option Award |
2020-08-19 12:53 pm |
N/A N/A |
GILEAD SCIENCES INC | GILD | Parsey Merdad Chief Medical Officer |
182 | $57.43 | 0 (Direct) |
View |
Ownership |
2020-07-13 5:59 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Parsey Merdad Director |
0 | $0 | 0 (Direct) |
View |